SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-024592
Filing Date
2017-05-04
Accepted
2017-05-04 17:02:36
Documents
55
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v464829_10q.htm 10-Q 411562
2 EXHIBIT 31.1 v464829_ex31-1.htm EX-31.1 12372
3 EXHIBIT 31.2 v464829_ex31-2.htm EX-31.2 12180
4 EXHIBIT 32.1 v464829_ex32-1.htm EX-32.1 4745
5 EXHIBIT 32.2 v464829_ex32-2.htm EX-32.2 4638
6 GRAPHIC pg16img1_10q.jpg GRAPHIC 155060
  Complete submission text file 0001144204-17-024592.txt   3714719

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT syn-20170331.xml EX-101.INS 840365
8 XBRL TAXONOMY EXTENSION SCHEMA syn-20170331.xsd EX-101.SCH 35954
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE syn-20170331_cal.xml EX-101.CAL 31788
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE syn-20170331_def.xml EX-101.DEF 197413
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE syn-20170331_lab.xml EX-101.LAB 262117
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE syn-20170331_pre.xml EX-101.PRE 231050
Mailing Address 155 GIBBS STREET SUITE 412 ROCKVILLE MD 20850
Business Address 617 DETROIT STREET, SUITE 100 ANN ARBOR MI 48104 (734) 332-7800
Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12584 | Film No.: 17814978
SIC: 2834 Pharmaceutical Preparations